Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
4.820
+0.070 (1.47%)
At close: Oct 7, 2026, 4:00 PM EDT
4.568
-0.252 (-5.23%)
Pre-market: Oct 8, 2026, 4:15 AM EDT
Sionna Therapeutics Employees
Sionna Therapeutics had 59 employees as of December 31, 2025. The number of employees increased by 18 or 43.90% compared to the previous year. That makes Sionna Therapeutics the 34,145th largest employer in the world and 4,551st in the United States.
Employees
59
Change
18
Growth
43.90%
Revenue / Employee
n/a
Profits / Employee
-$1,650,559
Market Cap
217.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 59 | 18 | 43.90% |
| Mar 31, 2025 | 48 | 20 | 71.43% |
| Dec 31, 2024 | 41 | 13 | 46.43% |
| Dec 31, 2023 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Lyell Immunopharma | 161 |
| Keros Therapeutics | 92 |
| Lineage Cell Therapeutics | 77 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
SION News
- 16 days ago - These beaten-down stocks could bounce back in January, if history is any guide - Market Watch
- 22 days ago - Sionna Therapeutics price target raised to $6 from $5 at Wedbush - TheFly
- 23 days ago - Sionna Therapeutics Transcript: Study update - Transcripts
- 23 days ago - Sionna Therapeutics Press release: Study update - Filings
- 23 days ago - Sionna Therapeutics Slides: Study update - Filings
- 23 days ago - Sionna Therapeutics to advance SION-451 + SION-2222 into AscenSION CF POC trial - TheFly
- 23 days ago - Sionna Therapeutics to reduce workforce by 46% - TheFly
- 23 days ago - Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial - GlobeNewsWire